About
us |
||||
| axxonis is
a product-driven pharmaceutical company with strong development potential
and with already established third parties agreements. The qualifications in the research and manufacturing area of these third partners complement axxonis expertise and enables axxonis to achieve the competitive advantage in the field of neurodegenerative diseases. axxonis acquires the rights to products or active pharmaceutical agents which can be developed efficiently for other valuable applications and indications. The strategy of product life cycle management allows a more cost and time efficient way of advancing rapidly into late stage development and launch. |
||||
|
||||
